Watchlist Price Alert

Mineralys Therapeutics In... (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

13.88

0.43 (3.20%)

At close: Jun 17, 2025, 3:17 PM

Mineralys Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-177.81M	-71.9M	-29.8M	-19.41M	-3.43M
Depreciation & Amortization	43K	n/a	n/a	n/a	n/a
Stock-Based Compensation	11.34M	5.06M	455K	80K	1K
Other Working Capital	9.1M	-7.47M	772K	4.08M	480K
Other Non-Cash Items	-9.4M	-6.87M	-649K	684K	482K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	9.52M	-7.47M	772K	4.08M	480K
Operating Cash Flow	-166.31M	-81.17M	-29.22M	-14.56M	-2.46M
Capital Expenditures	-96K	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-373.44M	-347.97M	-71.76M	n/a	n/a
Sales Maturities Of Investments	488.5M	187.5M	50M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-21.76K	n/a	n/a
Investing Cash Flow	114.96M	-160.47M	-21.76M	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-1.63M	n/a	-20K
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	83K	258K	n/a	n/a	3.85M
Financial Cash Flow	116.14M	203.25M	128.02M	23.81M	3.83M
Net Cash Flow	64.79M	-38.4M	77.04M	9.25M	1.37M
Free Cash Flow	-166.41M	-81.17M	-29.22M	-14.56M	-2.46M